—
Heparin is an unfractionated anticoagulant used for treatment and prophylaxis of thromboembolic disorders and as an anticoagulant in blood transfusions and dialysis.
| Dosage Form | IV / SC Injectable (Solution) |
| Strength | 1,000; 5,000; 10,000; 20,000 units/mL |
| Storage | Store at 20–25°C. |
| Category | Cardiovascular |
| Availability | Available for Transfer |
Treatment and prophylaxis of venous thromboembolism; anticoagulation during cardiac surgery and dialysis; DIC; acute coronary syndromes.
Binds to antithrombin III, accelerating the inactivation of thrombin (Factor IIa), Factor Xa, and other coagulation factors.
Each Burrard Pharmaceuticals technology transfer package for Heparin Sodium includes comprehensive documentation and support:
Complete formulation with manufacturing parameters, excipient specifications, and process controls.
Validated methods for assay, impurities, dissolution, and stability-indicating analysis.
Market-ready regulatory dossier sections for a named territory, scoped per programme.
ICH-compliant stability studies (accelerated and long-term) with detailed protocols.
Scale-up procedures, batch records, equipment specifications, and in-process controls.
Direct advisory access to formulation scientists and regulatory specialists throughout transfer.
Scope and timing for the complete know-how package are confirmed in writing after a confidentiality agreement. Book a consultation to discuss your specific requirements.